Synvitrobio accelerates bio-discovery through cell-free systems. Synvitrobio's Next Generation Expression platform allows for high-throughput data collection that is real and experimentally validated - not simulation.


supported by:

 
 

Cell-free systems are our engine.

 
 
 

 

A cell-free system is just like a cell, but with the cell wall removed. And what's left inside is endlessly fascinating. Cell-free systems allow us to do complex biochemistry without any of the limitations of a cell. This means reactions of endless complexity in 8 hours or less, compared to the weeks' to months' traditional biochemistry takes. We think of it as conserving the advantages of biology without the hassle - the ultimate prototyping system.

For a general review, see here. For our technical review, see here.

A company is only as good as its people.

 

Synvitrobio has recruited top experts in synthetic biology, cell-free systems, and early-stage company commercialization. We're excited to make an impact!

 
 

Founding Team

 
Zachary Sun, PhD Chief Executive Officer

Zachary Sun, PhD

Chief Executive Officer

George Church, PhD Professor, Harvard

George Church, PhD

Professor, Harvard

Richard Murray, PhD Professor, Caltech

Richard Murray, PhD

Professor, Caltech

 

Scientific and Commercial Advisors

 
Fred Kittler Director, Firelake Capital

Fred Kittler

Director, Firelake Capital

Michael Jewett, PhD Professor, Northwestern

Michael Jewett, PhD

Professor, Northwestern

Paul Freemont, PhD Professor, Imperial College London

Paul Freemont, PhD

Professor, Imperial College London

 

Execution Team

Abel Chiao Associate Scientist

Youngha Hwang Research Associate

Weng Ruh Wong, PhD Scientist

Richard Mansfield, MS ARE Fellow

We're taking alpha customers and collaborations.

 

Academic

Synvitrobio is preparing to sell E. coli cell-free systems for prototyping and expression for non-commercial academic use. We've optimized our extracts for prototyping of circuits and pathways by enabling native (or T7) expression and expression off of DNA. We are committed to advancing R&D in the cell-free academic community. Contact us for more details and to join the waitlist.

 

Industry

Synvitrobio can help diagnose your enzymes and your pathways in our E. coli cell-free system or a custom system. We're looking for engaged partners; contact us for more details.

 

 

We would love to hear from you.

 

info@synvitrobio.com

Synvitrobio, Inc.

953 Indiana St.

San Francisco, CA 94107

 
Name *
Name